Search | IOVS | ARVO Journals

Showing 1 – 20 of 98

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Port Delivery System With Ranibizumab (PDS) in diabetic macular edema (DME): additional primary analysis results of the phase 3 Pagoda trial

Varun Malhotra; Michael A. Klufas; Dennis M Marcus; Jordan M Graff; Peter A Campochiaro; Salman Rahman; Paul Latkany; Shamika Gune; Stephanie DeGraaf; Ashwini Bobbala; Mel Rabena; Carlos Ruiz; Arshad M. Khanani

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6233.

ARVO Annual Meeting Abstract June 2024

Suprachoroidal Gene Transfer with Nonviral Nanoparticles in Large Animal Eyes

Mingliang Zhang; JIkui Shen; Raquel Lima e Silva; Kathryn Luly; Sean Hackett; Stephany Tzeng; Shirley Lowmaster; Sydney Shannon; David Wilson; Jordan Green; Peter A Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2228.

ARVO Annual Meeting Abstract June 2023

Reproducibility of ellipsoid zone (EZ) parameters measured under different OCT scan settings in retinitis pigmentosa (RP)

Xiangrong Kong; Kevin Choy; Muhammad Khan; Yuchen Lu; Dagmar Wehling; Peter A Campochiaro; Glenn J Jaffe

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4659.

ARVO Annual Meeting Abstract June 2023

Efficacy Evaluation of EXG102-031, A Novel AAV-based Gene Therapy for Neovascular AMD in a Mouse Model of VEGF-A-induced Exudative Retinal Detachment vascular leakage Mouse Model

GUOJIE YE; Jikui Shen; Li Dai; Raquel Formica; Lijun Wang; Zhenhua Wu; Peter A Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1916.

Lecture November 2021

Retinal and Choroidal Vascular Diseases: Past, Present, and Future: The 2021 Proctor Lecture

PDF

Peter A. Campochiaro
TAGS: ischemia, pathogenesis, retinal diseases, vascular diseases, vascular endothelial growth factor a, injections, diabetic retinopathy, hypoxia
Invest. Ophthalmol. Vis. Sci.. 2021; 62(14):26. https://doi.org/10.1167/iovs.62.14.26

ARVO Annual Meeting Abstract June 2021

The design and patient acceptability of NAC Attack a phase-3 clinical trial for retinitis pigmentosa (RP)

Xiangrong Kong; Susie trotochaud; Fahd Naufal; Peter A Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3543.

ARVO Annual Meeting Abstract June 2021

Pharmacokinetic profile of the Port Delivery System with ranibizumab (PDS) in the phase 3 Archway trial

Peter A Campochiaro; Shamika Gune; Mauricio Maia; Han Ting Ding; Katie Maass

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):350.

ARVO Annual Meeting Abstract June 2021

Suppression of Murine Choroidal and Retinal Neovascularization by Risuteganib and the Accompanying Transcriptome Changes in the OIR Retina

Zixuan Shao; Sean F. Hackett; Raquel Formica; Yogita Kanan; Dan Zhou; John Y Park; Hampar L Karageozian; Vicken H Karageozian; Peter A Campochiaro; Julia A. Kornfield

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):186.

ARVO Annual Meeting Abstract June 2021

Prediction of Best-Corrected Visual Acuity from Optical Coherence Tomography in Patients with Neovascular Age-Related Macular Degeneration Using Deep Learning

Anam Akhlaq; Saleema A. Kherani; Craig Jones; Peter A Campochiaro; Tin Yan Liu

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):131.

ARVO Annual Meeting Abstract June 2020

Pharmacokinetic (PK) Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 2 Ladder Trial

Peter A Campochiaro; Shamika Gune; Mauricio Maia; Katie Maass

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1157.

ARVO Annual Meeting Abstract June 2020

Macular function response to N-acetylcysteine Treatment in patients with Retinitis Pigmentosa

Grace Tsai; Peter A Campochiaro; Xiangrong Kong

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1909.

ARVO Annual Meeting Abstract June 2020

Classification of disease severity in Retinitis Pigmentosa

Bushra Usmani; Mustafa Iftikhar; Marili Lemus; Peter A Campochiaro; Jose Alain Sahel; Hendrik P Scholl; Syed Mahmood Ali Shah

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3024.

ARVO Annual Meeting Abstract June 2020

Transgene Expression in RPE and Retina after Suprachoroidal delivery of AAV vectors

Kun Ding; Jikui Shen; Sean Hackett; Peter A Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4490.

ARVO Annual Meeting Abstract July 2019

Suprachoroidal AAV8-Vectored Gene Transfer Provides Widespread Transgene Expression in RPE and Retina

Kun Ding; Jikui Shen; Zibran Hafiz; Sean Hackett; Raquel Formica; Valeria E Lorenc; Rishi Chadha; Minie Zhang; Sherri Van Everen; Nicholas Buss; Michele Fiscella; Olivier Danos; Peter A Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2923.

ARVO Annual Meeting Abstract July 2019

Co-operative Activities of VEGF and SDF-1 in Retina

DA LONG; Jikui Shen; Sean Hackett; Lili Lu; Zibran Hafiz; Qiang Gong; Peter A Campochiaro; Jingwen Yu; Jinpeng Wang; Scott Ferguson; Wen-Chuan Chou; Qin Yang; Hui Kang

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3262.

ARVO Annual Meeting Abstract July 2019

A bispecific aptamer targeting both VEGF and Angiopoietin-2 for treating retinal diseases

Scott Ferguson; DA LONG; Qin Yang; Hui Kang; Jingwen Yu; Wen-Chuan Chou; Matthew Vukovich; Raquel Formica; Zibran Hafiz; Peter A Campochiaro; Jinpeng Wang; Qiang Gong

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3665.

ARVO Annual Meeting Abstract July 2019

AXT107, a Peptide that Disrupts Integrins, Suppresses Vascular Leakage in the Setting of Ocular Inflammation

Raquel Formica; Sean Hackett; Zibran Hafiz; Adam Mirando; Jordan J Green; Aleksander S Popel; Niranjan B Pandey; Peter A Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4073.

Retina October 2018

Three-Dimensional Transport Model for Intravitreal and Suprachoroidal Drug Injection

PDF

Yu Zhang; Hojjat Bazzazi; Raquel Lima e Silva; Niranjan B. Pandey; Jordan J. Green; Peter A. Campochiaro; Aleksander S. Popel

Invest. Ophthalmol. Vis. Sci.. 2018; 59(12):5266-5276. https://doi.org/10.1167/iovs.17-23632

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2018

Test-retest Reliability of MP1 and MAIA Microperimetry in Retinitis Pigmentosa

Mustafa Iftikhar; Jiangxia Wang; Peter A Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):30.

ARVO Annual Meeting Abstract July 2018

Progression of Retinitis Pigmentosa on Multimodal Imaging: The PREP-1 Study

Syed Mahmood Ali Shah; Mustafa Iftikhar; Bushra Usmani; Abanti Sanyal; Ramandeep Kaur; Marili Lemus; April Nefalar; Saleema A. Kherani; Simrat Sodhi; Saghar Bagheri; Etienne M Schonbach; Nadia Junaid; Peter A Campochiaro; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):45.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Port Delivery System With Ranibizumab (PDS) in diabetic macular edema (DME): additional primary analysis results of the phase 3 Pagoda trial

Suprachoroidal Gene Transfer with Nonviral Nanoparticles in Large Animal Eyes

Reproducibility of ellipsoid zone (EZ) parameters measured under different OCT scan settings in retinitis pigmentosa (RP)

Efficacy Evaluation of EXG102-031, A Novel AAV-based Gene Therapy for Neovascular AMD in a Mouse Model of VEGF-A-induced Exudative Retinal Detachment vascular leakage Mouse Model

Retinal and Choroidal Vascular Diseases: Past, Present, and Future: The 2021 Proctor Lecture

The design and patient acceptability of NAC Attack a phase-3 clinical trial for retinitis pigmentosa (RP)

Pharmacokinetic profile of the Port Delivery System with ranibizumab (PDS) in the phase 3 Archway trial

Suppression of Murine Choroidal and Retinal Neovascularization by Risuteganib and the Accompanying Transcriptome Changes in the OIR Retina

Prediction of Best-Corrected Visual Acuity from Optical Coherence Tomography in Patients with Neovascular Age-Related Macular Degeneration Using Deep Learning

Pharmacokinetic (PK) Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 2 Ladder Trial

Macular function response to N-acetylcysteine Treatment in patients with Retinitis Pigmentosa

Classification of disease severity in Retinitis Pigmentosa

Transgene Expression in RPE and Retina after Suprachoroidal delivery of AAV vectors

Suprachoroidal AAV8-Vectored Gene Transfer Provides Widespread Transgene Expression in RPE and Retina

Co-operative Activities of VEGF and SDF-1 in Retina

A bispecific aptamer targeting both VEGF and Angiopoietin-2 for treating retinal diseases

AXT107, a Peptide that Disrupts Integrins, Suppresses Vascular Leakage in the Setting of Ocular Inflammation

Three-Dimensional Transport Model for Intravitreal and Suprachoroidal Drug Injection

Test-retest Reliability of MP1 and MAIA Microperimetry in Retinitis Pigmentosa

Progression of Retinitis Pigmentosa on Multimodal Imaging: The PREP-1 Study

To View More...

You must be signed into an individual account to use this feature.